NRT Smoking Cessation Aids in Belgium
NRT SMOKING CESSATION AIDS IN BELGIUM
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
E-cigarettes Pose Serious Threat Despite Tough Local Legislation
Only New and Fast-acting Formats Have A Chance To Succeed
Belgium Not Ready To Adopt the Eur10 Pack
Competitive Landscape
Janssen-cilag Is Most Impacted by the Bleak Performance of 2018
Niquitin Manages To Rebound While Nicotinell Collapses
Limited Innovation and Focus on Tactical Advertising
Category Indicators
Table 1 Number of Smokers by Gender 2013-2018
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2013-2018
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2013-2018
Table 4 Sales of NRT Gum by Flavour: % Value 2013-2018
Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2014-2018
Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2015-2018
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023
Executive Summary
Differing Fates for OTC Products and Other Consumer Health
Non-otc Products Also Have Their Own Constraints
Generic, Medium-sized And/or Local Manufacturers Fare Better Than Ethical Multinationals
Movement Within Distribution
Manufacturers Remain Wary of Future Legislation
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 10 Life Expectancy at Birth 2013-2018
Market Data
Table 11 Sales of Consumer Health by Category: Value 2013-2018
Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format: % Value 2013-2018
Table 17 Distribution of Consumer Health by Format and Category: % Value 2018
Table 18 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches
Definitions
Sources
Summary 2 Research Sources
Most players are disappointed and concerned about the outlook for NRT smoking cessation aids due to the increasing sales of vapour products (not included in consumer health). Whilst sales took off later in Belgium than in other countries, e-cigarettes were suspected of cannibalising sales of NRT smoking cessation aids over 2014/2015. Thus, the recovery of sales of NRT smoking cessation aids in 2016 and the announcement of tougher regulations on vapour products was seen as “good news” for the cat...
Euromonitor International's NRT Smoking Cessation Aids in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.